Seeking Alpha

Theravance Inc. (THRX)

()

Comments on THRX

  • BioMed Updates: Merck KGaA, BioMarin, Cytori and Theravance [View article]
    You are beginning to tell us things we can find out on our own. You once provided some value added.
    Comment by dual cit
    Dec 2 17:31 pm |
    Rating: +2 -1
  • BioMed Updates: Merck KGaA, BioMarin, Cytori and Theravance [View article]
    Cytori is hot right now.Have traded this twice already.Big future for this one.
    Comment by KJP712
    Dec 1 01:54 am |
    Rating: +1 -1
  • Theravance, Inc.: Wait to Buy on Dip [View article]
    No surprise, Theravance says FDA delays new Vitabiv decision Theravance says FDA wants more data before ruling on Vitabix for... More »
    Comment by Penn Bioinvestor
    Nov 27 15:17 pm |
    Rating: +1 0
  • Theravance, Inc.: Wait to Buy on Dip [View article]
    Theravance's Horizon program is a long-acting beta2 agonist that can be taken as an inhaled medicine once a day and can be combined with... More »
    Comment by Penn Bioinvestor
    Nov 26 15:56 pm |
    Rating: +1 0
  • Theravance, Inc.: Wait to Buy on Dip [View article]
    On September 11, 2009, the U.S. Food and Drug Administration (FDA) approved VIBATIV for the treatment of adult patients with complicated... More »
    Comment by Penn Bioinvestor
    Nov 26 11:54 am |
    Rating: +2 0
  • Theravance, Inc.: Wait to Buy on Dip [View article]
    ''The FDA is anticipated to decide on 11/26/09 for Vibativ (telavancin) ...The announcement follows the approval of the drug by the U.S.... More »
    Comment by dharma_bear
    Nov 26 10:59 am |
    Rating: 0 0
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    Was the cat fight really necessary? This about investing.
    Comment by Geebo
    Nov 23 15:17 pm |
    Rating: +1 -1
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    Who are you? The cap of the world? Daniel was nice to provide a link to something that is otherwise unreachable and as you said no... More »
    Comment by MateState
    Nov 19 12:27 pm |
    Rating: 0 -1
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    Point taken. Thanks for the response Daniel. On Nov 18 01:40 PM Daniel Eskin wrote: > Greetings Dividend Inc, > > It seems odd... More »
    Comment by Dividend Inc
    Nov 18 14:42 pm |
    Rating: 0 0
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    I have an original copy of Margin Of Safety, which sells for .....hold on....$700 on the net. It is an awesome work of finance. I think... More »
    Comment by roy piper
    Nov 18 13:44 pm |
    Rating: 0 0
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    Check out www.gurufocus.com for summaries of returns of all well known financial firms - this one is definitely on there. On Nov 18... More »
    Comment by Daniel Eskin
    Nov 18 13:41 pm |
    Rating: 0 0
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    Greetings Dividend Inc, It seems odd that you're highly concerned with what e-mail address I'm using for personal reasons and that... More »
    Comment by Daniel Eskin
    Nov 18 13:40 pm |
    Rating: +1 -2
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    does anyone know what Baupost's 2008 return was? I have not seen that number anywhere. Given his limited interest in shorting and his... More »
    Comment by Gus McRae
    Nov 18 12:24 pm |
    Rating: +1 -1
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    Greetings Daniel Eskin, It seems odd to unabashedly market your blog through the use of your Deloitte email address offering material... More »
    Comment by Dividend Inc
    Nov 18 12:21 pm |
    Rating: +3 -3
  • Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
    sclem7 - clearly you're making way more than 20% annualized a year to not be trusting him =) I've been following Seth Klarman on... More »
    Comment by Daniel Eskin
    Nov 18 11:35 am |
    Rating: +3 -1